{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:55:42Z","timestamp":1764330942827},"reference-count":14,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2018,2,10]],"date-time":"2018-02-10T00:00:00Z","timestamp":1518220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,2,10]],"date-time":"2018-02-10T00:00:00Z","timestamp":1518220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Glaxo Smith Kline"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Perspect Psychiatr Care"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1111\/ppc.12258","type":"journal-article","created":{"date-parts":[[2018,2,10]],"date-time":"2018-02-10T14:02:58Z","timestamp":1518271378000},"page":"507-513","source":"Crossref","is-referenced-by-count":9,"title":["The use of brexpiprazole amongst individuals with insufficient outcomes with aripiprazole or bupropion: A case series"],"prefix":"10.1155","volume":"54","author":[{"given":"Traci","family":"Aladeen","sequence":"first","affiliation":[{"name":"Dent Neurologic Institute; Amherst NY USA"},{"name":"University at Buffalo School of Pharmacy and Pharmaceutical Sciences; Buffalo NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Westphal","sequence":"additional","affiliation":[{"name":"Dent Neurologic Institute; Amherst NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yena","family":"Lee","sequence":"additional","affiliation":[{"name":"Mood Disorders Psychopharmacology Unit; Toronto Western Hospital; University Health Network; Toronto Ontario Canada"},{"name":"Institute of Medical Science; University of Toronto; Toronto Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carola","family":"Rong","sequence":"additional","affiliation":[{"name":"Mood Disorders Psychopharmacology Unit; Toronto Western Hospital; University Health Network; Toronto Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Rainka","sequence":"additional","affiliation":[{"name":"Dent Neurologic Institute; Amherst NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horacio","family":"Capote","sequence":"additional","affiliation":[{"name":"Dent Neurologic Institute; Amherst NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[{"name":"Mood Disorders Psychopharmacology Unit; Toronto Western Hospital; University Health Network; Toronto Ontario Canada"},{"name":"Institute of Medical Science; University of Toronto; Toronto Ontario Canada"},{"name":"Department of Psychiatry; University of Toronto; Toronto Ontario Canada"},{"name":"Department of Pharmacology; University of Toronto; Toronto Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2018,2,10]]},"reference":[{"issue":"3","key":"10.1111\/ppc.12258-BIB0001|ppc12258-cit-0001","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/wps.20346","article-title":"How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence","volume":"15","author":"Cuijpers","year":"2016","journal-title":"World Psychiatry"},{"issue":"Suppl. 1","key":"10.1111\/ppc.12258-BIB0002|ppc12258-cit-0002","first-page":"20","article-title":"Treating to target in major depressive disorder: response to remission to functional recovery","volume":"20","author":"McIntyre","year":"2015","journal-title":"CNS Spectr"},{"key":"10.1111\/ppc.12258-BIB0003|ppc12258-cit-0003","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1741-7015-11-126","article-title":"Toward the future of psychiatric diagnosis: the seven pillars of RDoC","volume":"11","author":"Cuthbert","year":"2013","journal-title":"BMC Med"},{"issue":"6","key":"10.1111\/ppc.12258-BIB0004|ppc12258-cit-0004","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1017\/S0033291711002170","article-title":"Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report","volume":"42","author":"Rush","year":"2012","journal-title":"Psychol Med"},{"issue":"1","key":"10.1111\/ppc.12258-BIB0005|ppc12258-cit-0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/da.20046","article-title":"Standardized clinical outcome rating scale for depression for use in clinical practice","volume":"22","author":"Zimmerman","year":"2005","journal-title":"Depress Anxiety"},{"issue":"1","key":"10.1111\/ppc.12258-BIB0006|ppc12258-cit-0006","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/2045125316672136","article-title":"Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole","volume":"7","author":"Frankel","year":"2017","journal-title":"Ther Adv Psychopharmacol"},{"issue":"1","key":"10.1111\/ppc.12258-BIB0007|ppc12258-cit-0007","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JCP.0000000000000622","article-title":"Adjunctive brexpiprazole as a novel effective strategy for treating major depressive disorder: a systematic review and meta-analysis","volume":"37","author":"Yoon","year":"2017","journal-title":"J Clin Psychopharmacol"},{"issue":"12","key":"10.1111\/ppc.12258-BIB0008|ppc12258-cit-0008","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.4088\/JCP.15m10470","article-title":"Adjunctive brexpiprazole in patients with major depressive disorder and irritability: an exploratory study","volume":"77","author":"Fava","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/ppc.12258-BIB0009|ppc12258-cit-0009","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jad.2016.05.013","article-title":"Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: results from a post-hoc analysis of two randomised controlled trials","volume":"201","author":"McIntyre","year":"2016","journal-title":"J Affect Disord"},{"issue":"5","key":"10.1111\/ppc.12258-BIB0010|ppc12258-cit-0010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12325-015-0207-3","article-title":"Real-world determinants of adjunctive antipsychotic prescribing for patients with major depressive disorder and inadequate response to antidepressants: a case review study","volume":"32","author":"McIntyre","year":"2015","journal-title":"Adv Ther"},{"issue":"8","key":"10.1111\/ppc.12258-BIB0011|ppc12258-cit-0011","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/da.22378","article-title":"The American society of clinical psychopharmacology survey of psychopharmacologists'practice patterns for the treatment of mood disorders","volume":"32","author":"Goldberg","year":"2015","journal-title":"Depress Anxiety"},{"issue":"4","key":"10.1111\/ppc.12258-BIB0012|ppc12258-cit-0012","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4088\/PCC.v06n0403","article-title":"A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor","volume":"6","author":"Stahl","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"2","key":"10.1111\/ppc.12258-BIB0013|ppc12258-cit-0013","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0253-7176.92067","article-title":"Analysis of adverse drug reactions of atypical antipsychotic drugs in psychiatry OPD","volume":"33","author":"Piparva","year":"2011","journal-title":"Indian J Psychol Med"},{"key":"10.1111\/ppc.12258-BIB0014|ppc12258-cit-0014","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pbb.2016.12.015","article-title":"Involvement of presynaptic 5-HT1A receptors in the low propensity of brexpiprazole to induce extrapyramidal side effects in rats","volume":"153","author":"Mombereau","year":"2017","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Perspectives in Psychiatric Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fppc.12258","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ppc.12258\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:17:45Z","timestamp":1671542265000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ppc.12258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,10]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"URL":"https:\/\/doi.org\/10.1111\/ppc.12258","archive":["Portico"],"relation":{},"ISSN":["0031-5990"],"issn-type":[{"value":"0031-5990","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2,10]]}}}